| |
Mean difference *
|
95% CI for mean difference
|
SD difference
|
Limits of agreement
|
|---|
| |
Lower limit
|
Upper limit
|
Lower limit
|
Upper limit
|
|---|
|
INR
|
− 0.03
|
− 0.05
|
− 0.01
|
0.05
|
− 0.13
|
0.07
|
|
APTTr
|
− 0.07
|
− 0.13
|
− 0.02
|
0.18
|
0.42
|
0.28
|
|
Fibrinogen (g/L)
|
− 0.06
|
− 0.22
|
0.09
|
0.51
|
− 1.06
|
0.93
|
|
D-Dimer (mg/L)
|
− 4.5
|
− 0.15
|
0.21
|
2.4
|
− 5.2
|
4.2
|
|
TGA: maximum thrombin generation (nM)
|
− 26.6
|
− 70.2
|
16.9
|
151.6
|
− 323.7
|
270.4
|
|
TGA: time to peak thrombin generation (mins)
|
2.1
|
− 0.4
|
4.6
|
8.5
|
− 14.5
|
18.7
|
|
PFSCA CT (s)
|
− 28.8ρ
|
− 53.4
|
− 4.2
|
86.6
|
− 198.5
|
140.9
|
|
PFSCE CT (s)
|
− 7.4
|
− 29.5
|
14.7
|
77.7
|
− 159.7
|
145.0
|
- APTTr activated partial thromboplastin time ratio, INR International Normalised Ratio, TGA thrombin generation assay, PFSCA platelet function assay using collagen/adenosine diphosphate, PFSCE platelet function assay using collagen/epinephrine, CT closure time, CI confidence interval, SD standard deviation
- *Average difference between results of systemic samples and intra-circuit samples
